¥»¯¸³Ì¨ÎÂsÄýª¬ºA
¬°800*600¡A«ØÄ³¨Ï
¥ÎIE4.0¥H¤WÂsÄý¾¹


 

 

 

 

 

 

±MÃD³ø¾É
¥þ¥Á¡u¼N¡v°°
©Úµ´¦¨¬°°°ÃĨü®`ªÌ¡I

¤å¡þ½s¿è³¡


¥h¦~©³¡AÃzµoµØÀÙÂå°|°²°ª¦åÀ£ÃÄ¢w¢w¡u¯ßÀu¿õ¡v¨Æ¥ó«á¡A°°ÃİÝÃD§ó¨ü¨ì¦U¬É°ª«×Ãöª`¡C¬°¤F¹ý ©³¥´À»°°ÃÄ¡A½Ã¥Í¸pÃĬF³B¤é«eµoªí¡u°°¸TÃĬd½r¤è®×¡v¡A¨Ã´£¿ô¥Á²³¥ÎÃÄ«eÀ³¡u°±¡E¬Ý¡EÅ¥¡v¡A ¬°¥Á²³¥ÎÃĦw¥þ§âÃö¡C

¡@¡@½Ã¥Í¸pÃĬF³B¬ìªøÀ¹³·µúªí¥Ü¡A°°ÃĤw¸g¦¨¬°¥þ²yÃö¤Áªº­«¤jijÃD¡A§Î¦P¦M®`¤HÃþ°·±dªº®£©Æ¥÷¤l ¡C¦b¥@¬É¦U°ê¿n·¥¬ãÀÀ°°ÃĨ¾¨î¹ïµ¦ªº¦P®É¡A½Ã¥Í¸p¥ç¥þ­±¥[±j¥»°ê°°Ãĺ޲z¬[ºc¡BÂåÃıM·~¤H­û °V½m¡B¤Î¥Á²³«Å¾É±Ð¨|¡A´£¤É¬d½r®Ä²v»P¥þ¥Á°°ÃÄ»{ª¾¡A¬°¥þ¥ÁÃĪ«¨Ï¥Î¦w¥þ¤Î°·±dÄY±K§âÃö¡C

¥´À»°°ÃÄ¡A¬°¥ÎÃĦw¥þ§âÃö
¡@¡@ ½Ã¥Í¸p¬°¤F¥´À»°°ÃÄ¡A«Ø¥ß¤£ªkÃĪ«¸ó³¡·|¬d½r¾÷¨î¡A°£¤F¨ü²z¥Á²³ÀËÁ|¡A¨Ã¦bºô¯¸¤W´£¨Ñ18ºØ±` ¨£°°¸TÃĪº¿ëÃѹÏÀÉ¡A¥B°w¹ï¹L¥h¤T¦~´¿¦³³c°â°°¸TÃĬö¿ýªºÂåÃijq¸ôªÌ«Ø¥ß¶Â¦W³æ¡C¬°¤F§ùµ´µØ ÀÙÂå°|°²ÃĨƥ󭫺t¡A½Ã¥Í¸p±À¥X¥ÎÃĦw¥þ¬ÛÃöªº¡uÃĪ«¸ê°Tºô¡v¡]drug.doh.gov.tw¡^¡C¦Ó¥¼¨Ó ±N¿n·¥«Ø¨î¡u¥þ°êÃļt±ÂÅv¸g¾P°Ó¸ê®Æ®w¡v¡B«Ø¥ß¬õ¥~½u¡]IR¡^§Ö³t°»´ú§Þ³N¤Î¼Ð·Ç«~¸ê®Æ®w¡A¤@ ¤è­±»²¾É¥Á¶¡¦¨¥ßªÀ¹Îªk¤H¥xÆW¥´À»¤£ªk¦æ°ÊÁp·ùTMPACT¡]Taiwan Medical Products Anti-Counterfeiting Taskforce¡^¡A»PWHO¤§IMPACT¡]International Medical Products Anti-Counterfeiting Taskforce¡^µ²¦X¡A¥´À»°°ÃÄ¡A¥t¤@¤è­±¤]±N¥[±j»P¥qªk°|·¾³q¡A½Ð¥qªk³æ ¦ì±q­«¶q¦D¡A¹ï©ó°°Ãĸo¥Ç±Ä¨ú¤£»´©ö¥æ«O¤§³B¸m¡C

¡@¡@ ¨Æ¹ê¤W¡A³\¦h°°¸TÃĨå¼§t¦³¯u«~ªº¦³®ÄÃľ¯¦¨¤À¡A§Y¨Ï§t¦³¦³®ÄÃľ¯¦¨¤À¡A¾¯¶q½Õ°t¤]¤£¥¿½T¡A ­Y¤£·VªA¥Î°°ÃÄ¡A¤£¶ÈµLªk¹F¨ì¹w´ÁªºÀø®Ä¡A§ó¦³¦M®`¥Í©R°·±d¤§¸·¡C·íªìµØÀÙÂå°|°²ÃĨƥó´N¬O ¦]¬°¯f±wªø´ÁªA¥Î¯ßÀu¡A¦h¦~¨Ó¦åÀ£³£±±¨î±o«Ü¦n¡F¦³¤@°}¤lµo²{·Ó±`ªAÃÄ«oµLªk±±¨î¦åÀ£¡A¨­Åé ¤£¾A¡A¦^°|¬Ý¶E¡AÂå¥Í¤~µo²{¯f±wªA¥Îªº¬O°°ÃÄ¡C

¥ÎÃÄ¡u°±¡B¬Ý¡BÅ¥¡v

¡@¡@ ¥Ñ©ó°°ÃÄ»s³yªº§Þ³N¤é·s¤ë²§¡A´X¥i¶Ã¯u¡A½Ã¥Í¸pÃĬF³B¬ìªøÀ¹³·µú´£¿ô¥Á²³¡A¥ÎÃÄ«e­n¤Á°O¡u°± ¡B¬Ý¡BÅ¥¡v¡G
¡u°±¡v¡G°±¤î¦Û¤£¥¿·íªººÞ¹DÁʶRÃÄ«~¡A¥]¬Aºô¸ô¡B©]¥«¡B¼s¼½¹q¥xµ¥¡A¥HÁ×§K¶R¨ì°°ÃÄ¡C
¡u¬Ý¡v¡G¬Ý²M·¡ÃijU»¡©ú¡BÃÄ«~¥]¸Ë»P¥~Æ[¡C ³Ì¦n¨ú±o¦³§¹¾ã²°¸Ë¤§ÃÄ«~¡A»{²MÃÄ«~¨¾°°¼ÐÅÒ¥H«O»Ù¥ÎÃĦw¥þ¡C
¡uÅ¥¡v¡GÅ¥²M·¡ÃÄ®vªº»¡©ú¡A­Y¦³¥ÎÃİÝÃD¡A¥i¿n·¥¦VÃÄ®v¿Ô¸ß¡C


½Ã¥Í¸p¤£ªkÃĪ«¬d½r¾÷¨î
¡@¡@ ¬°½T«O°ê¤H¥ÎÃĤ§¦w¥þ¡A½Ã¥Í¸p¹ï¤£ªkÃĪ«¤§¨ú½l¤u§@¡A°£¥Ñ¦a¤è½Ã¥Í§½ÀH®É´NÁÒ°ÏÃİӻs³y¡A¿é ¤J©Î³c½æ¤§ÃĪ«¤Î¤ÆùÛ«~¶i¦æ½]¬d©M©âÅç¤u§@¡A¹ï©âÅ礣¦X®æªÌ¡A¨Ìªk¬d³B¥~¡A¨Ã¥Ñ½Ã¥Í¸pµ²¦X¦a ¤è½Ã¥Í§½¦¨¥ß¡uÁp¦X½r¬d¤p²Õ¡v¡A°t¦Xĵ¤è¤Î®ø¶OªÌ¥Nªí¡A°w¹ïÂåÀø°|©Ò¡BÃħ½¡BÃĩФΩ]¥«µ¥¦a ¡AÂX¤j¬d½r¤£ªkÃĪ«¡A¥H´£°ª¬d½r¦¨®Ä¡A¦³®Ä¥´À»§{¶¡¬y³q¤§¹H³WÃÄ«~¡B§ùµ´¤£ªkÃĪ«¬y«¡C

¡@¡@ ½Ã¥Í¸p°£¥[±j·þ¾É¦a¤è½Ã¥Í¾÷Ãö¨ú½l¹H³W¥~¡A¦P®É¥ç¹ªÀy¥Á²³¨ó§UºÊ·þÀËÁ|«Dªk¡A¨Ã³]¸m¡u¤£ªkÃÄ ª«±M¡v°Ï¡A¥H¨Ñ¥Á²³ÀËÁ|¤Î¿Ô¸ß¡C






 
 
| §K¶O¥[¤J·|­û/­Ó¤H¸ê®Æ­×§ï |
 
¹q¤l³ø ­q¾\/¨ú®ø/§ó·s ½Ð¿é¤JE-mail
¤T